482 related articles for article (PubMed ID: 28178892)
21. Nationwide population-based incidence of cancer among patients with HIV/AIDS in South Korea.
Lee SO; Lee JE; Lee S; Lee SH; Kang JS; Son H; Lee H; Kim J
Sci Rep; 2022 Jun; 12(1):9974. PubMed ID: 35705675
[TBL] [Abstract][Full Text] [Related]
22. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
23. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy.
Bower M; Palmieri C; Dhillon T
Curr Opin Infect Dis; 2006 Feb; 19(1):14-9. PubMed ID: 16374212
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer in women living with HIV.
D'Andrea F; Ceccarelli M; Facciolà A; Nunnari G; Pellicanò GF; Venanzi Rullo E
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1158-1164. PubMed ID: 30779085
[TBL] [Abstract][Full Text] [Related]
25. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.
Franceschi S; Lise M; Clifford GM; Rickenbach M; Levi F; Maspoli M; Bouchardy C; Dehler S; Jundt G; Ess S; Bordoni A; Konzelmann I; Frick H; Dal Maso L; Elzi L; Furrer H; Calmy A; Cavassini M; Ledergerber B; Keiser O;
Br J Cancer; 2010 Jul; 103(3):416-22. PubMed ID: 20588274
[TBL] [Abstract][Full Text] [Related]
26. Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).
Petoumenos K; van Leuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG;
HIV Med; 2013 Feb; 14(2):77-84. PubMed ID: 22934689
[TBL] [Abstract][Full Text] [Related]
27. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
Gabarre J; Bossi P
Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
[TBL] [Abstract][Full Text] [Related]
28. Cancer in HIV-infected persons from the Caribbean, Central and South America.
Fink VI; Shepherd BE; Cesar C; Krolewiecki A; Wehbe F; Cortés CP; Crabtree-Ramírez B; Padgett D; Shafaee M; Schechter M; Gotuzzo E; Bacon M; McGowan C; Cahn P; Masys D;
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):467-73. PubMed ID: 21239992
[TBL] [Abstract][Full Text] [Related]
29. Spectrum of cancer risk late after AIDS onset in the United States.
Simard EP; Pfeiffer RM; Engels EA
Arch Intern Med; 2010 Aug; 170(15):1337-45. PubMed ID: 20696958
[TBL] [Abstract][Full Text] [Related]
30. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy.
van Leeuwen MT; Vajdic CM; Middleton MG; McDonald AM; Law M; Kaldor JM; Grulich AE
AIDS; 2009 Oct; 23(16):2183-90. PubMed ID: 19734774
[TBL] [Abstract][Full Text] [Related]
31. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
Chaturvedi AK; Mbulaiteye SM; Engels EA
Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
[TBL] [Abstract][Full Text] [Related]
32. Excess cancers among HIV-infected people in the United States.
Robbins HA; Pfeiffer RM; Shiels MS; Li J; Hall HI; Engels EA
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663691
[TBL] [Abstract][Full Text] [Related]
33. Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.
Rubinstein PG; Aboulafia DM; Zloza A
AIDS; 2014 Feb; 28(4):453-65. PubMed ID: 24401642
[TBL] [Abstract][Full Text] [Related]
34. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Mukhtar F; Ilozumba M; Utuama O; Cimenler O
JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
[TBL] [Abstract][Full Text] [Related]
35. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.
Crum-Cianflone N; Hullsiek KH; Marconi V; Weintrob A; Ganesan A; Barthel RV; Fraser S; Agan BK; Wegner S
AIDS; 2009 Jan; 23(1):41-50. PubMed ID: 19050385
[TBL] [Abstract][Full Text] [Related]
36. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
37. The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.
Pipkin S; Scheer S; Okeigwe I; Schwarcz S; Harris DH; Hessol NA
AIDS; 2011 Feb; 25(4):463-71. PubMed ID: 21139489
[TBL] [Abstract][Full Text] [Related]
38. Trends in cancer risk among people with AIDS in the United States 1980-2002.
Engels EA; Pfeiffer RM; Goedert JJ; Virgo P; McNeel TS; Scoppa SM; Biggar RJ;
AIDS; 2006 Aug; 20(12):1645-54. PubMed ID: 16868446
[TBL] [Abstract][Full Text] [Related]
39. Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998.
Franceschi S; Dal Maso L; Pezzotti P; Polesel J; Braga C; Piselli P; Serraino D; Tagliabue G; Federico M; Ferretti S; De Lisi V; La Rosa F; Conti E; Budroni M; Vicario G; Piffer S; Pannelli F; Giacomin A; Bellù F; Tumino R; Fusco M; Rezza G;
J Acquir Immune Defic Syndr; 2003 Sep; 34(1):84-90. PubMed ID: 14501799
[TBL] [Abstract][Full Text] [Related]
40. AIDS-related cancer and severity of immunosuppression in persons with AIDS.
Biggar RJ; Chaturvedi AK; Goedert JJ; Engels EA;
J Natl Cancer Inst; 2007 Jun; 99(12):962-72. PubMed ID: 17565153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
